# Signal Detection in Monoclonal and New Agents in Lymphoma

> **NCT02849912** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 1671 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **OTHER:** questionnaire

## Key facts

- **NCT ID:** NCT02849912
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-09
- **Target enrollment:** 1671 (ACTUAL)
- **Last updated:** 2016-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02849912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02849912, "Signal Detection in Monoclonal and New Agents in Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02849912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*